Corrigendum: Dr Reddy's Labs-Abbot Merck Report

In the story titled 'Dr Reddy’s likely to get $40 mn from Abbott & Merck', we inadvertently mentioned Dr Reddy's in place of Dishman Pharma. The story has been withdrawn. We are extremely sorry for the error and for any inconvenience it may have c...